Retrospective analysis of tacrolimus combined with Tripterygium wilfordii polyglycoside for treating idiopathic membranous nephropathy

BMC Nephrology
Shun-Lai ShangXiangmei Chen

Abstract

Idiopathic membranous nephropathy (IMN) is one of the most common adult nephrotic syndromes. Some patients with this disorder require immunosuppressive therapy. This retrospective case series was performed to assess the effects of tacrolimus (TAC) combined with Tripterygium wilfordii polyglycoside (TWG) in treating IMN. From January 2015 to August 2016, kidney-biopsy-proven IMN patients treated with TAC in the Chinese PLA General Hospital were screened. Data were retrieved from the patients' medical records. The first efficacy evaluation index was remission rate (complete remission and partial remission), and the secondary efficacy evaluation indices included relapse rate, proteinuria, serum albumin and estimated glomerular filtration rate (eGFR). Adverse events were also assessed. The included patients' treatments were tacrolimus monotherapy (TAC group, n = 33), tacrolimus combined with methylprednisolone (MP) (TAC + MP group, n = 24) and tacrolimus combined with Tripterygium wilfordii polyglycoside (TAC + TWG group, n = 21). The remission rates of the TAC, TAC + MP, and TAC + TWG groups in the 10th month were 54.5, 62.5, and 85.7%, respectively (TAC + TWG group vs TAC group, P = 0.037, TAC + TWG group vs TAC + MP group, P = 0...Continue Reading

References

Nov 24, 1998·Immunopharmacology·Y YangL Li
Feb 19, 2000·Rheumatic Diseases Clinics of North America·X Tao, P E Lipsky
Jan 12, 2002·Kidney International·Arndt T PetermannStuart J Shankland
Mar 28, 2002·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alfons SegarraLuis L Piera
Nov 29, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Peggy W G du Buf-VereijkenJack F M Wetzels
Mar 31, 2006·Kidney International·S TroyanovD C Cattran
Mar 23, 2007·Kidney International·M PragaUNKNOWN Grupo Español de Estudio de la Nefropatía Membranosa
May 15, 2007·Journal of the American Society of Nephrology : JASN·Vivekanand JhaVinay Sakhuja
Apr 25, 2008·Journal of the American Society of Nephrology : JASN·Michelle P Winn
Jul 3, 2009·The New England Journal of Medicine·Laurence H BeckDavid J Salant
Feb 6, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Julia M Hofstra, Jack F M Wetzels
Mar 12, 2010·The American Journal of the Medical Sciences·Min ChenUNKNOWN Chinese Nephropathy Membranous Study Group
Apr 10, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Richard J Glassock
Jul 9, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Julia M Hofstra, Jack F M Wetzels
Mar 13, 2014·Journal of the American Society of Nephrology : JASN·Elion HoxhaRolf A K Stahl
Dec 11, 2014·Clinical and Experimental Nephrology·Norifumi HayashiHitoshi Yokoyama
Jul 5, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Elion HoxhaRolf A K Stahl
Apr 7, 2016·International Journal of Molecular Sciences·Danping FanAiping Lu
Aug 19, 2016·Kidney Diseases·Jing XuNan Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.